Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of active peptide compound in rhizoma sparganii

A technology of compounds and peptides, applied in the field of medicine, can solve the problems of undiscovered active ingredients, complex chemical components of triangular prisms, and staying, and achieve the effect of filling technical gaps, good anticoagulation, and good anticoagulant activity.

Active Publication Date: 2014-01-29
GUANGDONG PHARMA UNIV
View PDF1 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, the chemical composition of trigonium is complex, containing compounds such as flavonoids and flavonoid glycosides, phenylpropanoid glycosides, steroids and their glycosides, organic acids, although modern chemical and pharmacological studies have partially clarified the connection between chemical components and clinical applications , but there are still many active ingredients that have not been found, and many pharmacological studies only stay at the stage of extracts, which limits the further promotion and application of triangular compounds

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of active peptide compound in rhizoma sparganii
  • Application of active peptide compound in rhizoma sparganii
  • Application of active peptide compound in rhizoma sparganii

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0031] Example 1 Extraction, separation, purification and structural identification of compounds represented by formula (I)

[0032] 1. Experimental materials:

[0033] (1) medicinal materials

[0034] Sanleng medicinal material was purchased from Guangzhou Zhixin Pharmaceutical Co., Ltd., batch number 090301, and was identified by Professor Li Shuyuan from the Department of Traditional Chinese Medicine Identification, School of Traditional Chinese Medicine, Guangdong University of Pharmacy Sparganium stoloniferum Buch.-Ham Dried tuber peeled off.

[0035] (2) Reagents and fillers

[0036] Chloroform (analytical grade, Tianjin Fuyu Fine Chemical Co., Ltd.);

[0037] Methanol (analytical pure, Tianjin Fuyu Fine Chemical Co., Ltd.);

[0038] Vanillin (Guangzhou Guanglianjin Chemical Factory);

[0039] Silica gel for column chromatography (80-100 mesh, 100-200 mesh, 200-300 mesh, Qingdao Ocean Chemical Factory);

[0040] Thin-layer chromatography silica gel (silica gel ...

Embodiment 2

[0073] Embodiment 2 Anticoagulant function test of compound described in the present invention

[0074] 1. Experimental materials

[0075] (1) Drugs

[0076] Cyclic dipeptide cyclo-(tyrosine-leucine) prepared in Example 1.

[0077] (2) animals

[0078] SD rats, weighing 180-250 g, were provided by the Experimental Animal Center of Guangzhou University of Traditional Chinese Medicine.

[0079] (3) Reagents

[0080] Heparin (sigma, batch number: 20120509);

[0081] Chloral hydrate (Guangzhou Sile Biochemical Reagent Co., Ltd.);

[0082] Prothrombin time PT kit (Nanjing Jiancheng Institute of Bioengineering, batch number: 20130314);

[0083] Activated partial thromboplastin time APTT kit (Nanjing Jiancheng Bioengineering Institute, batch number: 20130201);

[0084] Thrombin time TT kit (Nanjing Jiancheng Institute of Bioengineering, batch number: 20130314);

[0085] Normal saline (Guizhou Tiandi Pharmaceutical Co., Ltd., batch number A13011209);

[0086] Dimethyl sulfoxi...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of an active peptide compound in rhizoma sparganii to the preparation of anticoagulant and / or antithrombotic drugs. The active peptide compound has the structural formula (I) shown in the specification. The invention firstly provides the peptide compound obtained from the rhizoma sparganii by separating and purifying and the application of the peptide compound. The compound has a trend prolonging effect for the prothrombin time (PT), activated partial thromboplastin time (APTT) and thrombin time (TT), has favorable anticoagulation activity and provides a powerful basis for the development of natural antithrombotic drugs.

Description

technical field [0001] The invention relates to the technical field of medicine, and more specifically, relates to the application of a peptide active compound in a triangular prism. Background technique [0002] Trigonum trigonum Sparganium stoloniferum The dried tuber of Buch.-Ham was first recorded in "Supplement to Materia Medica", and now it is recorded in "Chinese Pharmacopoeia". In addition to raw products and vinegar products used alone in traditional Chinese medicine, curcuma and astragalus are often used to enhance the curative effect. [0003] Modern pharmacological research shows that among the 35 commonly used drugs for promoting blood circulation and removing blood stasis, Sanleng ranks in the top 10 in terms of action strength, and is widely used in the treatment of cardiovascular and cerebrovascular diseases, tumors and various gynecological diseases. Especially for gynecological difficult diseases such as uterine fibroids and endometriosis, Sanleng has sh...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K38/12A61P7/02
Inventor 梁生旺王淑美邓小慧陈舒茵刘贝胡旭光闫天磊
Owner GUANGDONG PHARMA UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products